1go9: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1go9.gif|left|200px]]<br /><applet load="1go9" size="350" color="white" frame="true" align="right" spinBox="true"
[[Image:1go9.gif|left|200px]]
caption="1go9" />
 
'''MONITORING THE STRUCTURAL CONSEQUENCES OF PHE12-->D-PHE12 AND LEU15-->AIB15 SUBSTITUTION IN H/R CORTICOTROPIN RELEASING HORMONE: IMPLICATIONS FOR DESIGN OF CRH ANTAGONISTS.'''<br />
{{Structure
|PDB= 1go9 |SIZE=350|CAPTION= <scene name='initialview01'>1go9</scene>
|SITE=  
|LIGAND= <scene name='pdbligand=NH2:AMINO GROUP'>NH2</scene>
|ACTIVITY=
|GENE=
}}
 
'''MONITORING THE STRUCTURAL CONSEQUENCES OF PHE12-->D-PHE12 AND LEU15-->AIB15 SUBSTITUTION IN H/R CORTICOTROPIN RELEASING HORMONE: IMPLICATIONS FOR DESIGN OF CRH ANTAGONISTS.'''
 


==Overview==
==Overview==
Line 7: Line 16:


==About this Structure==
==About this Structure==
1GO9 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/ ] with <scene name='pdbligand=NH2:'>NH2</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1GO9 OCA].  
1GO9 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/ ]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1GO9 OCA].  


==Reference==
==Reference==
Monitoring the structural consequences of Phe12--&gt;D-Phe and Leu15--&gt;Aib substitution in human/rat corticotropin releasing hormone. Implications for design of CRH antagonists., Spyroulias GA, Papazacharias S, Pairas G, Cordopatis P, Eur J Biochem. 2002 Dec;269(24):6009-19. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=12473096 12473096]
Monitoring the structural consequences of Phe12--&gt;D-Phe and Leu15--&gt;Aib substitution in human/rat corticotropin releasing hormone. Implications for design of CRH antagonists., Spyroulias GA, Papazacharias S, Pairas G, Cordopatis P, Eur J Biochem. 2002 Dec;269(24):6009-19. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/12473096 12473096]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Cordopatis, P.]]
[[Category: Cordopatis, P.]]
Line 21: Line 30:
[[Category: solid phase synthesis]]
[[Category: solid phase synthesis]]
[[Category: solutions structure]]
[[Category: solutions structure]]
[[Category: synthetic analogues]]
[[Category: synthetic analogue]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:52:13 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 11:25:44 2008''